Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF – Get Free Report) shares shot up 4.4% on Wednesday . The company traded as high as $2.2872 and last traded at $2.2872. 5,200 shares were traded during trading, a decline of 72% from the average session volume of 18,475 shares. The stock had previously closed at $2.1907.
Sinopharm Group Price Performance
The stock has a 50-day simple moving average of $2.37 and a 200-day simple moving average of $2.48.
Sinopharm Group Company Profile
Sinopharm Group Co, Ltd is one of China’s largest state-owned integrated healthcare companies, primarily focused on the research, development, production and distribution of a broad range of pharmaceutical and healthcare products. Established in 1998 through the reorganization of assets under China National Pharmaceutical Group (Sinopharm), the company has grown to encompass multiple business segments, including prescription medicines, over-the-counter drugs, vaccines and medical devices. Sinopharm Group is listed on the Hong Kong Stock Exchange and trades in the United States through its OTCMKTS ticker SHTDF.
The company’s product portfolio spans chemically synthesized drugs, biologics and traditional Chinese medicine formulations, supported by an extensive nationwide manufacturing and quality-control network.
Featured Articles
- Five stocks we like better than Sinopharm Group
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
